Important Dates &
Upcoming Meetings

 

For details of related meetings, a regularly updated list of all meetings and conferences taking place can be found here.

 

30 March- 2 April 2008
EBMT Annual Congress
Click here

 

  • 1-6 March, 2008
    Sofia, Bulgaria
    2nd ESO Masterclass in Oncology Nursing (European School of Oncology)
    Click here
  • 5-9 March, 2008
    Antalya, Turkey
    5th National Bone Marrow & Stem Cell Therapies Congress

    Included in the programme will be a joint certification course and examination with EBMT-NG called 1st Stem Cell Transplantation Nurse Certification Programme.

    Topics covered will be: Venous Access, Chemotherapy Administration, GVHD Care and Mucositis."
    Click here
  • 27-29 March, 2008
    Geneva, Switzerland
    6th EONS Spring Convention (European Oncology Nursing Society)
    Click here

    •  

  • 30 March- 2 April 2008
    EBMT Annual Congress, Florence, Italy
    34th Annual Meeting of the European Group for Blood and Marrow Transplantation
     
    24th Meeting of the EBMT Nurses Group
     
    7th Meeting of the EBMT Data Management Group
     
    2nd EBMT Patient & Family Day
    Click here
  • April 1, 2008
    EBMT NG Exchange Visit & Education Scolarship Deadline
    Applications for scholarships should be submitted to Erik Aerts
    Further information
    Click here
  • June 2-4, 2008
    Poznan, Poland
    6th Meeting of the EBMT Paediatric Disease Working Party

    1st Meeting of the EBMT Paediatric Nurses
    Click here
  • June 4-7, 2008
    Lugano, Switzerland
    10th International Conference on Malignant Lymphoma
    Click here
  • June 15 -19, 2008
    Ljubljana, Slovenia
    17th WCET Congress (World Council of Enterostomal Therapists)
    Click here
  • August 17-21, 2008
    Singapore
    15th ISNCC International Conference (International Society of Nurses in Cancer Care)

    Early registration deadline is 29th February, 2008
    Click here

    •  

     

     

EBMT 2008, Florence, Italy

TARGETED THERAPY IN CML:
IMPROVING ADHERENCE, IMPROVING OUTCOMES

Don’t miss this special satellite symposium at the EBMT Conference that will be held on Sunday, March 30th, between 9-10.30am

In recent years the management of chronic myeloid leukaemia (CML) has been revolutionised by the availability of tyrosine kinase inhibitors (TKI) that target the BCR-ABL protein. Adherence to TKIs is of critical importance to CML outcomes with both cytogenetic and molecular responses strongly correlated to imatinib plasma trough levels. However, some patients struggle to adhere to long-term therapy with oral TKIs.

Non-adherence to medicines has been described by the World Health Organisation as “a worldwide problem of striking magnitude”. It is associated with unnecessary disease progression, disease complications, reduced quality of life and even death.  Medicines non-adherence is a complex and multi-faceted problem that is influenced by behavioural, social, economic, medical and policy factors which makes it very difficult to tackle effectively.  Frontline health professionals, especially nurses, play a key role in promoting medicines adherence and, therefore, it is important that they are aware of the scope of the problem and how best to manage it.  With this in mind Novartis Oncology is pleased to organise a satellite symposium at the EBMT Conference which will be held in Florence in March 2008. This symposium, which will take place on Sunday March 30th between 9-10.30am, aims to:

  • Highlight the different factors that contribute to CML outcomes
  • Review therapeutic and monitoring strategies that can be employed to improve CML outcomes
  • Raise awareness about the scope of non-adherence to long-term oral therapies in the haematology setting
  • Discuss ways in which patients can be encouraged to adhere to oral CML therapies.

The symposium will include four presentations and an interactive session where the audience will have the opportunity to contribute to discussions on how best to promote adherence to CML therapies and help improve CML outcomes. Speakers will include a haematology nurse specialist, two CML experts and a CML patient patient. 

All nurses attending EBMT are invited to this special symposium to learn more about how to improve medicines adherence in the haematology setting.  Further details about the satellite symposium can be found on the EBMT Conference Website.

 


EBMT Satellite Symposium - Florence, Italy
Sunday, March 30 2008 09:00-10:30

Chairman
 Fabrizio Pane, MD
Chair of Haematology, University of Naples Federico II & CEINGE Biotecnologie Avanzate, Naples Italy
09:00
 Opening remarks.
Fabrizio Pane, MD
Chair of Haematology, University of Naples Federico II & CEINGE Biotecnologie Avanzate, Naples Italy
09:05
 Optimising CML outcomes: the role of TKIs
Gianantonio Rosti, MD
Institute of Haematology "Seràgnoli", University of Bologna, Italy
09:25 
 The role and impact of imatinib blood level monitoring in CML
Francois-Xavier Mahon, MD, PhD
Laboratoire Hématopoïèse Normale et Leucemique, Université Victor Ségalen Bordeaux, France
09:40
 Promoting adherence to oral TKIs: the challenges faced
Monica Fliedner, MSN
President, EBMT Nurses Group and Clinical Nurse Specialist Oncology, Inselspital Bern, Switzerland
09:55 
 Complying and persisting with CML treatment: the patient perspective
Sandy Craine
CML Support, UK
10:10
 Discussion
10:25
 Closing remarks
Fabrizio Pane, MD
Chair of Haematology, University of Naples Federico II & CEINGE Biotecnologie Avanzate, Naples Italy